Part of our Year in Review series It was quite a diverse year in terms of our reporting: from breaking news coverage of stories like Australia’s limited rescheduling of MDMA and psilocybin and MAPS PBC’s New Drug Application submission, through to special reports and deep dives like our postmortems of significant names in the psychedelics industry, such as Synthesis Institute and Field Trip.
